Your English writing platform
Discover LudwigSuggestions(2)
Exact(1)
Further, data exclusivity commitments are increasingly common within bilateral settings.
Similar(59)
This is, bizarrely enough, true — data exclusivity was the culprit).
It wants stronger and longer patent protection and also increased use of "data exclusivity".
When a new biologic was produced, the manufacturer usually obtained data exclusivity to protect the clinical trial data for the medicine, including safety and efficacy data.
The US wanted at least eight years of data exclusivity for biologics, when the Australian standard is five years.
Note that stronger copyright and patent protection, along with data exclusivity, is the opposite of free trade.
Further data is hard to come by.
Twelve years of data exclusivity is just about enough time for biologic firms to break even.
In fact, data exclusivity and patent registration are common TRIPS-plus pharmaceutical patent provisions undertaken at a bilateral level.
Data exclusivity allows companies to keep their proprietary research data on new biologics private for a specified period of time.
(Academic research suggests the ideal time frame for data exclusivity is a bit longer 13 years to 16 years).
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com